
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Follow us for regular updates on cell analysis technology news, events, and more. ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high performance cell analysis platforms for life science research. ACEAs xCELLigence Real-Time Cell Analysis instruments and NovoCyte aQuanteon flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research. More than 2,500 instruments have been placed globally, and have been used in more than 1,800 peer-reviewed publications
Cell-based assays,cardiotoxicity research,flow cytometry,immunotherapy,cell analysis,cancer research,drug screening,infectious disease research,stem cell research,antibody research,cell invasion,and cell migration
Acea biosciences operates in the Biotechnology research industry.
Acea biosciences's revenue is 11m - 100m
Acea biosciences has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.